DARLING, RYAN JAMES,DICKINSON, CRAIG DUANE,DRIVER, DAVID ALBERT,GONCIARZ, MALGORZATA DONATA
申请号:
CA2871656
公开号:
CA2871656A1
申请日:
2013.06.05
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
This present invention relates to pharmacologically potent and stable human fibroblast growth factor 21 (FGF21) variants, pharmaceutical compositions comprising FGF21 variants, and methods for treating type 2 diabetes, obesity, dyslipidemia, and/or metabolic syndrome using such variants.